The chemical substance with the name provided is a complex organic molecule characterized by multiple stereocenters and functional groups, including hydroxyl (-OH) groups and a tetrahydropyran ring. Its structure suggests it may exhibit significant biological activity, potentially serving as a natural product or a derivative thereof. The presence of multiple chiral centers indicates that it may exist in various stereoisomeric forms, which can influence its pharmacological properties. The molecule also features a long carbon chain with conjugated double bonds, which may contribute to its reactivity and interaction with biological targets. Additionally, the presence of both hydroxyl and carbonyl functionalities suggests potential for hydrogen bonding and reactivity in various chemical environments. Overall, this compound's intricate structure and functional diversity may make it of interest in medicinal chemistry, particularly in the development of therapeutic agents. Further studies would be necessary to elucidate its specific properties, including solubility, stability, and biological activity.

(2S)-2-{(2S,4S,6S)-2,4-dihydroxy-5,5-dimethyl-6-[(1E,3E)-penta-1,3-dien-1-yl]tetrahydro-2H-pyran-2-yl}-N-[(2E,4E,6S,7R)-7-{(2S,3S,4R,5R)-3,4-dihydroxy-5-[(1E,3E,5E)-7-(2-hydroxy-1-methyl-4-oxo-1,4-dihydropyridin-3-yl)-6-methyl-7-oxohepta-1,3,5-trien-1-yl]

66170-37-4: The chemical substance with the name provided is a complex organic molecule characterized by multiple stereocenters and functional groups, including hydroxyl (-OH) groups and a tetrahydropyran ring. Its structure suggests it may exhibit significant biological activity, potentially serving as a natural product or a derivative thereof. The presence of multiple chiral centers indicates that it may exist in various stereoisomeric forms, which can influence its pharmacological properties. The molecule also features a long carbon chain with conjugated double bonds, which may contribute to its reactivity and interaction with biological targets. Additionally, the presence of both hydroxyl and carbonyl functionalities suggests potential for hydrogen bonding and reactivity in various chemical environments. Overall, this compound's intricate structure and functional diversity may make it of interest in medicinal chemistry, particularly in the development of therapeutic agents. Further studies would be necessary to elucidate its specific properties, including solubility, stability, and biological activity.

Heneicomycin is a precursor antibiotic of Aurodoxin.

CAS 66170-37-4

(2S)-2-{(2S,4S,6S)-2,4-dihydroxy-5,5-dimethyl-6-[(1E,3E)-penta-1,3-dien-1-yl]tetrahydro-2H-pyran-2-yl}-N-[(2E,4E,6S,7R)-7-{(2S,3S,4R,5R)-3,4-dihydroxy-5-[(1E,3E,5E)-7-(2-hydroxy-1-methyl-4-oxo-1,4-dihydropyridin-3-yl)-6-methyl-7-oxohepta-1,3,5-trien-1-yl]

Heneicomycin

Ref: TM-T27533